-
Ab177894-10mgMK-6105 (anti-IL-13Ra1) is a monoclonal antibody targeting IL13RA1. It can be used in research of therapeutic antibody for biological drug discovery.
-
Ab177894-1mgMK-6105 (anti-IL-13Ra1) is a monoclonal antibody targeting IL13RA1. It can be used in research of therapeutic antibody for biological drug discovery.
-
Ab177894-5mgMK-6105 (anti-IL-13Ra1) is a monoclonal antibody targeting IL13RA1. It can be used in research of therapeutic antibody for biological drug discovery.
-
Ab177932-100μgNadecnemab (anti-GFRA3) is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab (anti-GFRA3) can be used for research of osteoarthritis of the knee/pain[1].
-
Ab177932-10mgNadecnemab (anti-GFRA3) is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab (anti-GFRA3) can be used for research of osteoarthritis of the knee/pain[1].
-
Ab177932-1mgNadecnemab (anti-GFRA3) is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab (anti-GFRA3) can be used for research of osteoarthritis of the knee/pain[1].
-
Ab177932-5mgNadecnemab (anti-GFRA3) is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab (anti-GFRA3) can be used for research of osteoarthritis of the knee/pain[1].
-
Ab177922-100μgNGM120 (anti-GFRAL) is a long-acting monoclonal antibody directed against glial-cell-derived neurotrophic factor (GDNF) family receptor alpha-like (GFRAL), with potential anti-anorexia and anti-cachexia activities. It binds to and blocks GFRAL
-
Ab177922-10mgNGM120 (anti-GFRAL) is a long-acting monoclonal antibody directed against glial-cell-derived neurotrophic factor (GDNF) family receptor alpha-like (GFRAL), with potential anti-anorexia and anti-cachexia activities. It binds to and blocks GFRAL
-
Ab177922-1mgNGM120 (anti-GFRAL) is a long-acting monoclonal antibody directed against glial-cell-derived neurotrophic factor (GDNF) family receptor alpha-like (GFRAL), with potential anti-anorexia and anti-cachexia activities. It binds to and blocks GFRAL
-
Ab177922-5mgNGM120 (anti-GFRAL) is a long-acting monoclonal antibody directed against glial-cell-derived neurotrophic factor (GDNF) family receptor alpha-like (GFRAL), with potential anti-anorexia and anti-cachexia activities. It binds to and blocks GFRAL
-
Ab177891-100μgNI-0701 (anti-CCL5) is a antibody tageting CCL5.